# Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.

> **NCT03458624** · — · UNKNOWN · sponsor: **Kang Stem Biotech Co., Ltd.** · enrollment: 14 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03458624
- **Lead sponsor:** Kang Stem Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07-01
- **Primary completion:** 2016-08-12
- **Final completion:** 2018-12-31
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2018-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03458624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03458624, "Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03458624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*